Craig Horbinski
Craig Horbinski
Verified email at
Cited by
Cited by
Epidemiologic and molecular prognostic review of glioblastoma
JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom, DD Lightner, ...
Cancer Epidemiology and Prevention Biomarkers 23 (10), 1985-1996, 2014
Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death
J Zhu, C Horbinski, F Guo, S Watkins, Y Uchiyama, CT Chu
The American journal of pathology 170 (1), 75-86, 2007
DMT1: a mammalian transporter for multiple metals
MD Garrick, KG Dolan, C Horbinski, AJ Ghio, D Higgins, M Porubcin, ...
Biometals 16 (1), 41-54, 2003
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
J Zhao, AX Chen, RD Gartrell, AM Silverman, L Aparicio, T Chu, ...
Nature medicine 25 (3), 462-469, 2019
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer
ML Zhu, CM Horbinski, M Garzotto, DZ Qian, TM Beer, N Kyprianou
Cancer research 70 (20), 7992-8002, 2010
CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells
AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ...
Cancer research 76 (19), 5671-5682, 2016
Kinase signaling cascades in the mitochondrion: a matter of life or death
C Horbinski, CT Chu
Free Radical Biology and Medicine 38 (1), 2-11, 2005
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
A Piunti, R Hashizume, MA Morgan, ET Bartom, CM Horbinski, ...
Nature medicine 23 (4), 493-500, 2017
Mitochondrial control by DRP1 in brain tumor initiating cells
Q Xie, Q Wu, CM Horbinski, WA Flavahan, K Yang, W Zhou, ...
Nature neuroscience 18 (4), 501-510, 2015
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ...
Neuro-oncology 22 (8), 1073-1113, 2020
Preferential iron trafficking characterizes glioblastoma stem-like cells
DL Schonberg, TE Miller, Q Wu, WA Flavahan, NK Das, JS Hale, ...
Cancer cell 28 (4), 441-455, 2015
An overview of meningiomas
RA Buerki, CM Horbinski, T Kruser, PM Horowitz, CD James, RV Lukas
Future Oncology 14 (21), 2161-2177, 2018
Diagnostic Use of IDH1/2 Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues
C Horbinski, J Kofler, LM Kelly, GH Murdoch, MN Nikiforova
Journal of Neuropathology & Experimental Neurology 68 (12), 1319-1325, 2009
Cancer stem cell‐specific scavenger receptor CD36 drives glioblastoma progression
JS Hale, B Otvos, M Sinyuk, AG Alvarado, M Hitomi, K Stoltz, Q Wu, ...
Stem cells 32 (7), 1746-1758, 2014
Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas
C Horbinski, RL Hamilton, Y Nikiforov, IF Pollack
Acta neuropathologica 119 (5), 641-649, 2010
Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis
F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ...
Clinical Cancer Research 22 (21), 5337-5348, 2016
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma
M Venere, C Horbinski, JF Crish, X Jin, A Vasanji, J Major, AC Burrows, ...
Science translational medicine 7 (304), 304ra143-304ra143, 2015
What do we know about IDH1/2 mutations so far, and how do we use it?
C Horbinski
Acta neuropathologica 125 (5), 621-636, 2013
Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas
C Horbinski, MN Nikiforova, JM Hagenkord, RL Hamilton, IF Pollack
Neuro-oncology 14 (6), 777-789, 2012
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
TE Miller, BB Liau, LC Wallace, AR Morton, Q Xie, D Dixit, DC Factor, ...
Nature 547 (7663), 355-359, 2017
The system can't perform the operation now. Try again later.
Articles 1–20